Guangyu Xu
Key Laboratory Of Chemical Biology And Traditional Chinese Medicine, Key Laboratory Of The Assembly And Application Of Organic Functional Molecules Of Hunan Province
Changsha, 410081, China
Changsha, 410081, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Design, synthesis and biological evaluation of the activity-based probes for FGFR covalent inhibitor.
Journal: European journal of medicinal chemistry
Published: March 04, 2025
Integrative Multi-Omics Approaches Reveal Selectivity Profiles and Molecular Mechanisms of FIIN-2, a Covalent FGFR Inhibitor.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 08, 2024
Design, synthesis, and biological evaluation of selective covalent inhibitors of FGFR4.
Journal: European journal of medicinal chemistry
Published: January 21, 2024
A triphenylamine-based fluorescent probe with phenylboronic acid for highly selective detection of Hg2+ and CH3Hg+ in groundwater.
Journal: Organic & biomolecular chemistry
Published: June 22, 2023
Nucleophilic functionalizations of indole derivatives using the aromatic Pummerer reaction.
Journal: Organic & biomolecular chemistry
Published: April 26, 2022
Structure-based design of a dual-warhead covalent inhibitor of FGFR4.
Journal: Communications chemistry
Published: August 18, 2021
Thallium(I) Salts: New Partners for Calix[4]pyrroles.
Journal: Organic letters
Published: March 18, 2021
Isolation and characterization of novel process-related impurities in empagliflozin.
Journal: Journal of pharmaceutical and biomedical analysis
Published: December 08, 2020
Discovery of a novel AR/HDAC6 dual inhibitor for prostate cancer treatment.
Journal: Aging
Published: June 15, 2020
Selective Inclusion of Fluoride within the Cavity of a Two-Wall Bis-calix[4]pyrrole.
Journal: Organic letters
Published: May 15, 2020
Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors.
Journal: Cells
Published: May 15, 2019
Characterization of FGF401 as a reversible covalent inhibitor of fibroblast growth factor receptor 4.
Journal: Chemical communications (Cambridge, England)
Published: May 02, 2019
Last Updated: 09/26/2026